Latest Breaking News On - Ascendi annual report - Page 1 : comparemela.com

Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024

- 40% of efficacy-evaluable patients (2 out of 5) in the initial cohort of patients with anti-PD-1 refractory melanoma treated with TransCon IL-2.

United-states
Copenhagen
Køavn
Denmark
American
Chicago-may
Stina-singel
Melinda-baker
Ascendis-pharma
Tim-lee
Head-of-clinical-development
Exchange-commission

Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024

Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United-states
Massachusetts
Cincinnati
Ohio
Copenhagen
Køavn
Denmark
Boston
University-of-cincinnati
Beverly-mk-biller
Aimee-shu
Mike-gordon

Ascendis Pharma: Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial

Ascendis Pharma: Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Denmark
Japan
United-states
Copenhagen
Køavn
United-kingdom
China
Great-britain
Peter-schwarz
Aimee-shu
Tim-lee
Melinda-baker

Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024

Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with Chronic Hypoparathyroidism to Be Presented at ECE 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Stockholm
Sweden
United-kingdom
China
Denmark
Japan
United-states
Evisen
Vastra-gotalands-lan
Copenhagen
Køavn
Great-britain

Ascendis Pharma (ASND) to Present Latest Clinical and Quality-of-Life Data for TransCon PTH-Treated Adults with Chronic Hypoparathyroidism

Ascendis Pharma (ASND) to Present Latest Clinical and Quality-of-Life Data for TransCon PTH-Treated Adults with Chronic Hypoparathyroidism
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stockholm
Sweden
Japan
China
Denmark
Copenhagen
Køavn
Evisen
Vastra-gotalands-lan
United-kingdom
United-states
Great-britain